News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
Thursday, April 20, 2023Virax Biolabs Group Limited an innovative biotech company focused on the detection of immune responses to and diagnosis of viral diseases announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits The...
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
Wednesday, April 19, 2023Harvard Bioscience Inc announced the initial order for the Companys new highcapacity behavioral monitoring system for preclinical applications This initial order which was placed by one of the Companys large contract research organization CRO custome...
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
Wednesday, April 19, 2023Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders announced today an update on the Companys US Food Drug Administration FDA Phase clinical trial th...
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
Tuesday, April 18, 2023HUTCHMED China Limited announces that its New Drug Application NDA for fruquintinib in combination with paclitaxel for the treatment of secondline advanced gastric or gastroesophageal junction adenocarcinoma in China has been accepted for review by t...
Araris Biotech AG Acquires ARS Pharmaceutical’s Nectin-4 Antibody
Tuesday, April 18, 2023Araris Biotech AG a company pioneering a proprietary antibodydrug conjugate ADClinker technology today announced the execution of an asset purchase agreement for the acquisition of ARS Pharmaceuticals Nectin antibody The antibody was initially develo...
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
Saturday, April 15, 2023Navidea Biopharmaceuticals Inc a company focused on the development of precision immunodiagnostic agents and immunotherapeutics today announced it has signed an Asset Purchase Agreement allowing Meilleur Technologies Inc Meilleur to acquire certain a...
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity
Thursday, April 13, 2023Aspect Biosystems and Novo Nordisk AS today announced a collaboration development and licence agreement to develop bioprinted tissue therapeutics designed to replace repair or supplement biological functions inside the body with the aim of delivering...
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
Thursday, April 13, 2023Chiesi Farmaceutici SpA an international researchfocused biopharmaceuticals and healthcare group today announced the completion of the acquisition of Amryt Pharma Plc a global commercialstage biopharmaceutical company dedicated to acquiring developin...
Humacyte Completes Enrollment in Phase 3 Trial of Human Acellular Vessel™ (HAV™) for Hemodialysis Access in End-Stage Renal Disease Patients
Wednesday, April 12, 2023Humacyte Inc a clinicalstage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale today announced it has completed enrollment of a Phase trial in hemodialysis access The V Trial is designed...
Recce Pharmaceuticals to be Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives
Wednesday, April 12, 2023Recce Pharmaceuticals Ltd the Company developing a new class of synthetic antiinfectives is pleased to announce the Australian Patent Office issued notification of intent to grant Recce a new family four patent Process for Preparation of Biologically...
